Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Healthcare Medical Devices
Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Therma Bright Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(417)
•••
Post by Zimmee1on May 17, 2021 10:55am
113 Views
Post# 33213807

Look at his potential of this stock as now $0.38:

Look at his potential of this stock as now $0.38:



Realtime quote for V:THRM as of 10:52:40 EDT
You have been charged 2.0¢ C

Click here for another realtime quote for this security

Recent Trades - Last 10 of 250
Time ET Ex Price Change Volume Buyer Seller Markers
10:52:17 V 0.385 0.025 2,000 79 CIBC 79 CIBC K
10:52:17 V 0.385 0.025 1,500 79 CIBC 79 CIBC K
10:49:22 V 0.38 0.02 3,000 1 Anonymous 1 Anonymous K
10:49:22 V 0.38 0.02 2,000 1 Anonymous 79 CIBC K
10:49:22 V 0.38 0.02 150 62 Haywood 80 National Bank  
10:47:46 V 0.38 0.02 500 80 National Bank 80 National Bank K
10:47:46 V 0.38 0.02 1,000 80 National Bank 79 CIBC K
10:47:37 V 0.375 0.015 1,000 7 TD Sec 7 TD Sec K
10:47:22 V 0.38 0.02 2,000 79 CIBC 79 CIBC K

10:52:40 EDT Mon 17 May 2021
V:THRM - THERMA BRIGHT INC - https://www.thermabright.com 10:52:40 EDT - 
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
THRM - V   37.0 0.38 · 0.39 40.5 0.385 +0.025 6.9 606.2 227 250 0.365  0.395  0.36 1.05  0.02 10:52:17 May 06 realtime
TSX-V - V 37.0 0.38 · 0.39 40.5 0.385 +0.025 6.9 462.1 173 172 0.365  0.395  0.36 1.05  0.02 10:52:17   realtime
NEO ATS - U   0.38 +0.02 5.6 54.5 20 13 0.36  0.38  0.36   10:32:31   15 min
Alpha - A   0.37 +0.01 2.8 24.0 9 5 0.365  0.38  0.365   10:07:44   15 min
Omega - O   0.375 +0.015 4.2 2.5 1 2 0.365  0.375  0.365   09:59:54   15 min
Chi-X - X   0.38 +0.02 5.6 32.0 12 14 0.36  0.38  0.36   10:32:31   15 min
CX2 - H   0.38 +0.02 5.6 26.8 10 18 0.365  0.38  0.365   10:03:17   15 min

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities